Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Efficacy of a blended low-intensity internet-delivered psychological programme in patients with multimorbidity in primary care: Study protocol for a randomized controlled trial

  • Monreal-Bartolomé, A.
  • Barceló-Soler, A.
  • Castro, A.
  • Pérez-Ara, M.Á.
  • Gili, M.
  • Mayoral, F.
  • Hurtado, M.M.
  • Moreno, E.V.
  • Botella, C.
  • García-Palacios, A.
  • Baños, R.M.
  • López-Del-Hoyo, Y.
  • García-Campayo, J.
Background: The World Health Organization (WHO) has included comorbidity between depression and a chronic disease among the 10 leading global health priorities. Although there is a high prevalence of multimorbidity, health care systems are mainly designed for the management of individual diseases. Given the difficulty in delivering face-to-face psychological treatments, alternative models of treatment delivery have been proposed, emphasizing the role of technologies such as the Internet. The aim of this study is to assess the efficacy in Primary Care (PC) of a blended low-intensity psychological intervention applied using information and communication technologies (ICTs) for the treatment of multimorbidity in PC (depression and type 2 diabetes/low back pain) by means of a randomized controlled trial (RCT). Our main hypothesis is that improved usual care combined with psychological therapy applied using ICTs will be more efficacious for improvement in the symptomatology of multimorbidity, compared to a group with only improved treatment as usual six months after the end of treatment. Methods: A protocol has been designed combining a face-to-face intervention with a supporting online programme that will be tested by an RCT conducted in three different regions (Andalusia, Aragon and the Balearic Islands). The RCT will evaluate three hundred participants diagnosed with depression and type 2 diabetes/low back pain. Four highly experienced research groups specializing in clinical psychology are involved in this trial, and there will be ample possibilities for translation and transfer to usual clinical practice. Discussion: This clinical trial will lead to improvement in financial sustainability, maximizing the use of resources and responding to principles of efficiency and effectiveness. Furthermore, based on the evaluation of the feasibility of implementing this intervention in primary care facilities, we expect to be able to suggest the intervention for incorporation into public policy. In conclusion, positive results of this study could have a significant impact on one of the most important health-related problems, multimorbidity. Trial registration: ClinicalTrials.gov, NCT03426709. Registered retrospectively on 08 February 2018.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Lipid-lowering response in subjects with the p.(Leu167del) mutation in the APOE gene

  • Bea, A.M.
  • Lamiquiz-Moneo, I.
  • Marco-Benedí, V.
  • Mateo-Gallego, R.
  • Pérez-Calahorra, S.
  • Jarauta, E.
  • Martín, C.
  • Cenarro, A.
  • Civeira, F.
Background and aims: The aim of this work was to compared the effect of lipid lowering drugs among familial hypercholesterolemia (FH) subjects with a functional mutation in LDLR (LDLR FH) and FH with the p.(Leu167del) mutation in APOE. Methods: We retrospectively selected all adults with the p.(Leu167del) mutation on lipid-lowering treatment (n = 22) attending the Lipid Unit at the Hospital Miguel Servet. Age and sex matched LDLR FH from the same Unit were randomly selected as a control group (n = 44). Results: The mean percentage reduction in LDLc was significantly higher in the p.(Leu167del) carriers (-52.1%) than in the LDLR FH (-39.7%) (p = 0.040) when on high intensity statins. Similar differences between groups were observed in non-HDLc -49.4% and -36.4%, respectively (p = 0.030). Conclusions: Subjects with p.(Leu167del) mutation have a higher lipid-lowering response to statins with or without ezetimibe than LDLR FH. This supports the use of genetics for a more efficient management of FH.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia

  • Perez-Calahorra, S.
  • Laclaustra, M.
  • Marco-Benedí, V.
  • Lamiquiz-Moneo, I.
  • Pedro-Botet, J.
  • Plana, N.
  • Sanchez-Hernandez, R.M.
  • Amor, A.J.
  • Almagro, F.
  • Fuentes, F.
  • Suarez-Tembra, M.
  • Civeira, F.
Background and aims: The impact on heterozygous familial hypercholesterolemia (HeFH) health led by high-intensity lipid-lowering therapy (HILLT) is unknown, and the question remains if there is still an unacceptably high residual risk to justify treatment with new lipid-lowering drugs. Methods: This observational, retrospective, multicenter, national study in Spain, whose information was obtained from a national dyslipemia registry, was designed to establish the current prevalence of cardiovascular disease (CVD) in HeFH and to define the impact of HILLT on CVD in this population. Odds were estimated using several logistic regression models with progressive adjustment. Results: 1958 HeFH, mean age 49.3 ± 14.3 years, were included in the analysis. At inclusion in the registry, 295 patients (15.1%) had suffered CVD and 164 (55.6%) had suffered the first event before the onset lipid-lowering treatment. Exposition to treatment associated more than ten times lower odds for CVD than in subjects naïve to treatment (OR 0.085, 95% CI 0.063–0.114, p < 0.001). A first CVD event after a mean treatment period of 9.1 ± 7.2 years occurred in 131 out of 1615 (8.1%) HeFH subjects, and 115 (87.8%) of them were on HILLT. Conclusions: Current prevalence of CVD among HeFH is one third of that reported before the statins era. Early initiation and prolonged lipid-lowering treatment was associated with a reduction in CVD. New cases of CVD, in spite of HILLT, appeared mostly among patients accumulating risk factors and probably they may be considered for further lipid-lowering drugs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

  • Pin-Vieito, N.
  • Iglesias, M. J.
  • Remedios, D.
  • Rodríguez-Alonso, L.
  • Rodriguez-Moranta, F.
  • Álvarez-Sánchez, V.
  • Fernández-Bañares, F.
  • Boadas, J.
  • Martínez-Bauer, E.
  • Campo, R.
  • Bujanda, L.
  • Ferrandez, Á.
  • Piñol, V.
  • Rodríguez-Alcalde, D.
  • Guardiola, J.
  • Cubiella, J.
  • González-López, N.
  • Quintero, E.
  • Bañales, J.
  • Bujanda, L.
  • Perugorria, M. J.
  • Cleries, R.
  • Ribes, J.
  • Sanz, X.
  • López-Vicente, J.
  • Rodriguez-Alcalde, D.
  • Piñol, V.
  • Torrealba, L.
  • Blanco, I.
  • Cubiella, J.
  • Díaz-Ondina, M.
  • Salve, M.
  • Fernández-Seara, J.
  • Iglesias, M. J.
  • Macía, P.
  • Remedios, D.
  • Sánchez, E.
  • Vega, P.
  • Campo, R.
  • Martínez-Bauer, E.
  • Pujol, M.
  • Sánchez, V. Á.
  • Mera, J.
  • Turnes, J.
  • Clofent, J.
  • Garayoa, A.
  • Fernández-Bañares, F.
  • Gonzalo, V.
  • Pujals, M.
  • Boadas, J.
  • Galter, S.
  • Garcia-Lanuza, E.
  • Gimeno, R.
  • Alsius, A.
  • Ferrández, Á.
  • Sánchez, M. S.
BACKGROUND: Faecal immunochemical test (FIT) has been recommended to assess symptomatic patients for colorectal cancer (CRC) detection. Nevertheless, some conditions could theoretically favour blood originating in proximal areas of the gastrointestinal tract passing through the colon unmetabolized. A positive FIT result could be related to other gastrointestinal cancers (GIC). AIM: To assess the risk of GIC detection and related death in FIT-positive symptomatic patients (threshold 10 µg Hb/g faeces) without CRC. METHODS: Post hoc cohort analysis performed within two prospective diagnostic test studies evaluating the diagnostic accuracy of different FIT analytical systems for CRC and significant colonic lesion detection. Ambulatory patients with gastrointestinal symptoms referred consecutively for colonoscopy from primary and secondary healthcare, underwent a quantitative FIT before undergoing a complete colonoscopy. Patients without CRC were divided into two groups (positive and negative FIT) using the threshold of 10 µg Hb/g of faeces and data from follow-up were retrieved from electronic medical records of the public hospitals involved in the research. We determined the cumulative risk of GIC, CRC and upper GIC. Hazard rate (HR) was calculated adjusted by age, sex and presence of significant colonic lesion. RESULTS: We included 2709 patients without CRC and a complete baseline colonoscopy, 730 (26.9%) with FIT = 10 µgr Hb/gr. During a mean time of 45.5 ± 20.0 mo, a GIC was detected in 57 (2.1%) patients: An upper GIC in 35 (1.3%) and a CRC in 14 (0.5%). Thirty-six patients (1.3%) died due to GIC: 22 (0.8%) due to an upper GIC and 9 (0.3%) due to CRC. FIT-positive subjects showed a higher CRC risk (HR 3.8, 95%CI: 1.2-11.9) with no differences in GIC (HR 1.5, 95%CI: 0.8-2.7) or upper GIC risk (HR 1.0, 95%CI: 0.5-2.2). Patients with a positive FIT had only an increased risk of CRC-related death (HR 10.8, 95%CI: 2.1-57.1) and GIC-related death (HR 2.2, 95%CI: 1.1-4.3), with no differences in upper GIC-related death (HR 1.4, 95%CI: 0.6-3.3). An upper GIC was detected in 22 (0.8%) patients during the first year. Two variables were independently associated: anaemia (OR 5.6, 95%CI: 2.2-13.9) and age = 70 years (OR 2.7, 95%CI: 1.1-7.0). CONCLUSION: Symptomatic patients without CRC have a moderate risk increase in upper GIC, regardless of the FIT result. Patients with a positive FIT have an increased risk of post-colonoscopy CRC.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Lipid Profile Rather Than the LCAT Mutation Explains Renal Disease in Familial LCAT Deficiency

  • Lamiquiz-Moneo, I.
  • Civeira, F.
  • Gomez-Coronado, D.
  • Blanco-Vaca, F.
  • Villafuerte-Ledesma, H.M.
  • Gil, M.
  • Amigo, N.
  • Mateo-Gallego, R.
  • Cenarro, A.
Renal complications are the major cause of morbidity and mortality in patients with familial lecithin-cholesterol acyltransferase (LCAT) deficiency (FLD). We report three FLD patients, two of them siblings-only one of whom developed renal disease-and the third case being a young man with early renal disease. The aim of this study was to analyze the clinical characteristics and possible mechanisms associated with renal disease in these patients. Plasma lipid levels, LCAT activity, lipoprotein particle profile by NMR and FPLC, free and esterified cholesterol, presence of lipoprotein X (LpX) and DNA sequencing in the three FLD patients have been determined. The three cases presented clinical characteristics of FLD, although only one of the siblings developed renal disease, at 45 years of age, while the other patient developed the disease in his youth. Genetic analysis revealed new missense homozygous mutations, p.(Ile202Thr) in both siblings and p.(Arg171Glu) in the other patient. Lipoprotein particle analysis showed that the two patients with renal disease presented higher numbers of small very low-density lipoprotein (VLDL) and a higher concentration of triglycerides in VLDL. This study reports three new cases of LCAT deficiency, not previously described. Renal disease is not only dependent on LCAT deficiency, and could be due to the presence of VLDL particles, which are rich in triglycerides, free cholesterol and LpX.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort

  • Pin-Vieito, N.
  • Iglesias, M.J.
  • Remedios, D.
  • Alvarez-Sanchez, V.
  • Fernandez-Banares, F.
  • Boadas, J.
  • Martinez-Bauer, E.
  • Campo, R.
  • Bujanda, L.
  • Ferrandez, A.
  • Pinol, V.
  • Rodriguez-Alcalde, D.
  • Menendez-Rodriguez, M.
  • Garcia-Morales, N.
  • Perez-Mosquera, C.
  • Cubiella, J.
We aimed to assess the risk of cancer in patients with abdominal symptoms after a complete colonoscopy without colorectal cancer (CRC), according to the carcinoembryonic antigen (CEA) concentration, as well as its diagnostic accuracy. For this purpose, we performed a post-hoc analysis within a cohort of 1431 patients from the COLONPREDICT study, prospectively designed to assess the fecal immunochemical test accuracy in detecting CRC. Over 36.5 +/- 8.4 months, cancer was detected in 115 (8%) patients. Patients with CEA values higher than 3 ng/mL revealed an increased risk of cancer (HR 2.0, 95% CI 1.3-3.1), CRC (HR 4.4, 95% CI 1.1-17.7) and non-gastrointestinal cancer (HR 1.7, 95% CI 1.0-2.8). A new malignancy was detected in 51 (3.6%) patients during the first year and three variables were independently associated: anemia (OR 2.8, 95% CI 1.3-5.8), rectal bleeding (OR 0.3, 95% CI 0.1-0.7) and CEA level >3 ng/mL (OR 3.4, 95% CI 1.7-7.1). However, CEA was increased only in 31.8% (95% CI, 16.4-52.7%) and 50% (95% CI, 25.4-74.6%) of patients with and without anemia, respectively, who would be diagnosed with cancer during the first year of follow-up. On the basis of this information, CEA should not be used to assist in the triage of patients presenting with lower bowel symptoms who have recently been ruled out a CRC.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

  • Serrano-Lobo, J.
  • Gómez, A.
  • Sánchez-Yebra, W.
  • Fajardo, M.
  • Lorenzo, B.
  • Sánchez-Reus, F.
  • Vidal, I.
  • Fernández-Torres, M.
  • Sánchez-Romero, I.
  • de Alegría-Puig, C.R.
  • del Pozo, J.L.
  • Muñoz, P.
  • Escribano, P.
  • Guinea, J.
  • Sánchez-Gómez, J.
  • Lozano, I.
  • Marfil, E.
  • de la Rosa, M.M.
  • García, R.T.
  • Cobo, F.
  • Castro, C.
  • López, C.
  • Rezusta, A.
  • Peláez, T.
  • Castelló-Abietar, C.
  • Cos-Tales, I.
  • Serra, J.L.
  • Jiménez, R.
  • Echeverría, C.L.
  • Pérez, C.L.
  • Megías-Lobón, G.
  • Ayats, J.
  • Martín, M.T.
  • Sánchez-Hellín, V.
  • Ibáñez, E.
  • Pemán, J.
  • Pazos, C.
  • Rodríguez-Mayo, M.
  • Pérez-Ayala, A.
  • Gómez, E.
  • Serrano, J.
  • Reigadas, E.
  • Rodríguez, B.
  • Zvezdanova, E.
  • Díaz-García, J.
  • González Leiva, J.
  • Machado, M.
  • García-Rodríguez, J.
  • Vallejo, M.R.
  • López-Soria, L.
  • Marimón, J.M.
  • Vicente, D.
  • Hernáez-Crespo, S.
The EUCAST EDef 9.3.2 procedure recommends visual readings of azole and amphotericin B MICs against Aspergillus spp. Visual determination of MICs may be challenging. In this work, we aim to obtain and compare visual and spectrophotometric MIC readings of azoles and amphotericin B against Aspergillus fumigatus sensu lato isolates. A total of 847 A. fumigatus sensu lato isolates (A. fumigatus sensu stricto [n = 828] and cryptic species [n = 19]) were tested against amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole using the EUCAST EDef 9.3.2 procedure. Isolates were classified as susceptible or resistant/non-wild type according to the 2020 updated breakpoints. The area of technical uncertainty for the azoles was defined in the updated breakpoints. Visual and spectrophotometric (fungal growth reduction of >95% compared to the control, read at 540 nm) MICs were compared. Essential (+1 2-fold dilution) and categorical agreements were calculated. Overall, high essential (97.1%) and categorical (99.6%) agreements were found. We obtained 100% categorical agreements for amphotericin B, itraconazole, and posaconazole, and consequently, no errors were found. Categorical agreements were 98.7 and 99.3% for voriconazole and isavuconazole, respectively. Most of the misclassifications for voriconazole and isavuconazole were found to be associated with MIC results falling either in the area of technical uncertainty or within one 2-fold dilution above the breakpoint. The resistance rate was slightly lower when the MICs were obtained by spectrophotometric readings. However, all relevant cyp51A mutants were correctly classified as resistant. Spectrophotometric determination of azole and amphotericin B MICs against A. fumigatus sensu lato isolates may be a convenient alternative to visual endpoint readings.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Analysis of the Calls Received during the COVID-19 Lockdown by the Mental Health Crisis Helpline Operated by the Professional College of Psychology of Aragon

  • Monreal-Bartolomé, A.
  • López-Del-hoyo, Y.
  • Cabrera-Gil, I.
  • Aguilar-Latorre, A.
  • Puebla-Guedea, M.
  • Boira, S.
  • Lanero, J.
COVID-19 has had a direct impact on the physical and mental health of millions of people worldwide. Therefore, a Mental Health Crisis Helpline (MHCH) was set up and offered free of charge by the Professional College of Psychology of Aragon (COPPA) during the lockdown period. This research aims to study the reasons for the calls, to describe the population segments that used it, and to analyse the possible relationships between the variables studied. A total of 1411 calls were answered and 598 were registered. The main reasons for the calls were: anxiety symptoms, concern for a relative, previous mental health problems, conflicts, and depressive symptoms. Significantly more men called for anxiety symptoms (60.8% vs. 49.5%) versus more women calling regarding a chronic physical illness (3.5% vs. 0.7%), concern about a relative (22.7% vs. 12.4%), care guidelines (6% vs. 1.3%), and bereavement (6.2% vs. 2%). Calls regarding conflict increased slightly as the lockdown period progressed (p < 0.001; r = 0.15), in contrast with calls regarding previous psychological conditions and anxiety symptoms (p = 0.035; r = -0.09; p = 0.005; r = -0.12). These results highlight the intensive use of the MHCH, confirming the need for the implementation of specific psychological care resources in times of crisis. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Intrapericardial delivery of apa-microcapsules as promising stem cell therapy carriers in an experimental acute myocardial infarction model

  • Báez-Díaz C.
  • Blanco-Blázquez V.
  • Sánchez-Margallo F.M.
  • López E.
  • Martín H.
  • Espona-Noguera A.
  • Casado J.G.
  • Ciriza J.
  • Pedraz J.L.
  • Crisóstomo V.
The administration of cardiosphere-derived cells (CDCs) after acute myocardial infarction (AMI) is very promising. CDC encapsulation in alginate-poly-L-lysine-alginate (APA) could increase cell survival and adherence. The intrapericardial (IP) approach potentially achieves high concentrations of the therapeutic agent in the infarcted area. We aimed to evaluate IP therapy using a saline vehicle as a control (CON), a dose of 30 × 106 CDCs (CDCs) or APA microcapsules containing 30 × 106 CDCs (APA-CDCs) at 72 h in a porcine AMI model. Magnetic resonance imaging (MRI) was used to determine the left ventricular ejection fraction (LVEF), infarct size (IS), and indexed end diastolic and systolic volumes (EDVi; ESVi) pre-and 10 weeks post-injection. Programmed electrical stimulation (PES) was performed to test arrhythmia inducibility before euthanasia. Histopathological analysis was carried out afterwards. The IP infusion was successful in all animals. At 10 weeks, MRI revealed significantly higher LVEF in the APA-CDC group compared with CON. No significant differences were observed among groups in IS, EDVi, ESVi, PES and histopathological analyses. In conclusion, the IP injection of CDCs (microencapsulated or not) was feasible and safe 72 h post-AMI in the porcine model. Moreover, CDCs APA encapsulation could have a beneficial effect on cardiac function, reflected by a higher LVEF at 10 weeks. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Glycerol kinase deficiency in adults: Description of 4 novel cases, systematic review and development of a clinical diagnostic score

  • Lamiquiz-Moneo, I.
  • Mateo-Gallego, R.
  • Fernández-Pardo, J.
  • López-Ariño, C.
  • Marco-Benedí, V.
  • Bea, A.M.
  • Ferraro, L.
  • Jarauta, E.
  • Cenarro, A.
  • Civeira, F.
Background and aims: Glycerol kinase deficiency (GKD) is a rare genetic disorder characterized by hyperglycerolemia and glyceroluria, which could be misdiagnosed as a moderate to severe hypertriglyceridemia (HTG). We aimed to describe four novel cases of GKD, to complete a systematic review of all cases of isolated GKD published so far, and to develop a suspicion clinical diagnostic score for GKD. Methods: We reported four cases with suspicion of GKD and compared their phenotype with 584 males with triglycerides (TG) > 300 mg/dL, selected as control group (HTG non-GKD). The GK gene was sequenced in all cases. Lipoprotein particle concentrations were measured in all cases with GKD. The systematic review involved a PubMed, Cochrane and Scopus databases search to identify anthropometric and biochemical characteristics of all described cases with GKD. Results: The systematic review retrieved a total of 15 articles involving 39 subjects with GKD. GKD cases reported a history of high TG levels resistant to lipid-lowering therapy. Compared to GKD subjects (n = 43), HTG non-GKD subjects (n = 584) showed significantly higher BMI, total cholesterol, non-HDL cholesterol and gamma-glutamyltransferase, significantly lower HDL cholesterol and TG, and higher prevalence of diabetes. The proposed diagnostic score was significantly higher in GKD than in HTG non-GKD subjects. Conclusions: This is the first systematic review that compiles all GKD cases reported to date including 4 novel cases, and examine the differential GKD phenotype compared to other types of HTG. The proposed score would have a broad utility in clinical practice to avoid unwarranted lipid lowering treatment in GKD patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Optimization of Size and Operation of Stand-Alone Renewable-Based Systems with Diesel and Hybrid Pumped Hydro Storage–Battery Storage Considering Uncertainties

  • Dufo-López, Rodolfo
  • Lujano-Rojas, Juan M.
Currently, the electrical supply in stand-alone systems is usually composed of renewable sources with fossil-fuel generators and battery storage. This study shows a novel model for the metaheuristic–stochastic optimization (minimization of the net present cost, and NPC) of sizing and energy management for stand-alone photovoltaic (PV)–wind–diesel systems with hybrid pumped hydro storage (PHS)–battery storage systems. The model is implemented in C++ programming language. To optimize operations—thus reducing PHS losses and increasing battery lifetimes—optimal energy management can optimize the power limits of using the PHS or battery to supply or store energy. The probabilistic approach considers the variability of wind speed, irradiation, temperature, load, and diesel fuel price inflation. The variable efficiencies of the components and losses and advanced models for battery degradation are considered. This methodology was applied to Graciosa Island (Portugal), showing that, compared with the current system, the optimal system (with a much higher renewable power and a hybrid PHS–battery storage) can reduce the NPC by half, reduce life cycle emissions to 14%, expand renewable penetration to 96%, and reduce the reserve capacity shortage to zero.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Almost fine gradings on algebras and classification of gradings up to isomorphism

  • Elduque, Alberto
  • Kochetov, Mikhail
We consider the problem of classifying gradings by groups on a finite-dimensional algebra A (with any number of multilinear operations) over an algebraically closed field. We introduce a class of gradings, which we call almost fine, such that every G-grading on A is obtained from an almost fine grading on A in an essentially unique way, which is not the case with fine gradings. For abelian G, we give a method of obtaining all almost fine gradings if fine gradings are known. We apply these ideas to the case of semisimple Lie algebras in characteristic 0: to any abelian group grading with nonzero identity component, we attach a (possibly nonreduced) root system Φ and, in the simple case, construct an adapted Φ-grading.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Primary prevention in older adults: sex differences in statin persistence and cholesterol control

  • Malo, Sara
  • Rabanaque, María José
  • Gamba, Adriana
  • Vinuesa-Hernando, José Manuel
  • Moreno-Juste, Aida
  • Lallana, María Jesús
  • Cebollada, Jesús
  • Aguilar-Palacio, Isabel
Introduction and objectives: This study aimed to analyze sex differences in statin persistence and associated factors among individuals aged 70 years and older in Spain who initiated statin therapy for primary prevention of cardiovascular disease. Additionally, it assessed the role of sex in low-density lipoprotein cholesterol (LDL-C) control based on the intensity of statin therapy used. Methods: This was an observational longitudinal study conducted within the CARhES (Cardiovascular risk factors for health services research) cohort. Individuals aged ≥ 70 years who initiated statin therapy for primary prevention of cardiovascular disease between 2018 and 2020 were included. Two-year statin persistence was assessed by sex. Considering major cardiovascular events and death as competing risks, the risk of statin discontinuation and its associated factors were estimated using cumulative incidence functions and Fine and Gray analysis. The proportion of men and women achieving LDL-C target levels was also calculated. Results: A total of 4936 older adults (61.7% women) were included. Compared with men, women had higher mean LDL-C levels prior to statin initiation, a greater pharmacological burden, were less likely to receive high-intensity statins, and demonstrated lower persistence. No variables were statistically associated with discontinuation among women. In men, the adjusted HR for discontinuation was 1.03 (95%CI: 1.00-1.06) per 10 mg/dL increase in baseline LDL-C level. Among persistent statin users, women were less likely than men to achieve LDL-C targets, particularly when treated with low to moderate-intensity statins. Conclusions: Significant sex differences exist in statin persistence, associated factors, and achievement of LDL-C targets among older adults. These findings highlight the importance of considering sex-specific factors when evaluating the appropriateness of statin use in this population. Introducción y objetivos: El objetivo de este estudio fue analizar las diferencias por sexo en la persistencia al tratamiento con estatinas y los factores asociados en una población española mayor de 70 años que inició tratamiento con estatinas para la prevención primaria de la enfermedad cardiovascular. Además, se evaluó el papel del sexo en el control del colesterol unido a lipoproteínas de baja densidad (cLDL) en función de la intensidad del tratamiento con estatinas. Métodos: Estudio longitudinal observacional realizado en la cohorte CARhES (Cardiovascular risk factors for health services research) que incluyóa personas ≥ 70 años que iniciaron tratamiento con estatinas para la prevención primaria de enfermedades cardiovasculares entre 2018 y 2020. Se evaluó la persistencia al tratamiento con estatinas 2 años después en función del sexo. Se consideraron riesgos competitivos los eventos cardiovasculares mayores y la muerte, y se estimó el riesgo de interrumpir el tratamiento y sus factores asociados mediante funciones de incidencia acumulada y análisis de Fine y Gray. También se calculó la proporción de mujeres y varones que alcanzaron los niveles de cLDL recomendados. Resultados: Se incluyó un total de 4.936 personas mayores (61,7% mujeres). En comparación con los varones, las mujeres presentaron valores medios de cLDL más elevados antes de iniciar el tratamiento con estatinas, mayor carga farmacológica, menor probabilidad de recibir estatinas de alta intensidad y menor persistencia al tratamiento, sin variables asociadas a la interrupción. En los varones, la HR ajustada de interrupción del tratamiento fue de 1,03 (IC95%, 1,00-1,06) por cada incremento de 10 mg/dl en el cLDL. Entre los pacientes que seguían en tratamiento con estatinas, las mujeres tuvieron menos probabilidad que los varones de alcanzar los objetivos de cLDL, en particular si recibían tratamiento con estatinas de intensidad baja-moderada. Conclusiones: Existen diferencias significativas en función del sexo en la persistencia al tratamiento con estatinas, los factores asociados y el logro de los objetivos de cLDL entre las personas mayores. Estos hallazgos resaltan la importancia de considerar factores específicos de cada sexo el evaluar la idoneidad del uso de estatinas en esta población.